Published in PLoS One on October 05, 2011
Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease. Science (2014) 1.49
Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis. Am J Respir Crit Care Med (2012) 1.20
Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord. J Comp Neurol (2014) 1.09
Microglia centered pathogenesis in ALS: insights in cell interconnectivity. Front Cell Neurosci (2014) 1.00
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis. Cell Mol Life Sci (2013) 1.00
Human astrocytes derived from glial restricted progenitors support regeneration of the injured spinal cord. J Neurotrauma (2013) 0.99
Characterization of the Contribution of Genetic Background and Gender to Disease Progression in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis: A Meta-Analysis. J Neuromuscul Dis (2015) 0.92
Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice. Stem Cell Reports (2014) 0.90
Bioengineered stem cells in neural development and neurodegeneration research. Ageing Res Rev (2013) 0.89
Transplantation of D15A-expressing glial-restricted-precursor-derived astrocytes improves anatomical and locomotor recovery after spinal cord injury. Int J Biol Sci (2012) 0.89
Overexpression of the astrocyte glutamate transporter GLT1 exacerbates phrenic motor neuron degeneration, diaphragm compromise, and forelimb motor dysfunction following cervical contusion spinal cord injury. J Neurosci (2014) 0.89
Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis. Stem Cells Transl Med (2013) 0.84
Human iPS cell-derived astrocyte transplants preserve respiratory function after spinal cord injury. Exp Neurol (2015) 0.83
Transplantation of glial progenitors that overexpress glutamate transporter GLT1 preserves diaphragm function following cervical SCI. Mol Ther (2014) 0.83
ASTROCYTES: EMERGING STARS IN LEUKODYSTROPHY PATHOGENESIS. Transl Neurosci (2013) 0.82
Gene profiling of human induced pluripotent stem cell-derived astrocyte progenitors following spinal cord engraftment. Stem Cells Transl Med (2014) 0.82
Regenerative cellular therapies for neurologic diseases. Brain Res (2015) 0.82
Glia: an emerging target for neurological disease therapy. Stem Cell Res Ther (2012) 0.81
Acute intermittent hypoxia induced phrenic long-term facilitation despite increased SOD1 expression in a rat model of ALS. Exp Neurol (2015) 0.81
Recent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral Sclerosis. Neurotherapeutics (2015) 0.80
Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury. World J Stem Cells (2015) 0.80
Astrocyte-like cells derived from human oral mucosa stem cells provide neuroprotection in vitro and in vivo. Stem Cells Transl Med (2014) 0.78
Human glial progenitor engraftment and gene expression is independent of the ALS environment. Exp Neurol (2014) 0.77
Effect of type-2 astrocytes on the viability of dorsal root ganglion neurons and length of neuronal processes. Neural Regen Res (2014) 0.76
Combined transplantation of GDAs(BMP) and hr-decorin in spinal cord contusion repair. Neural Regen Res (2013) 0.75
Glial-Restricted Precursors Protect Neonatal Brain Slices from Hypoxic-Ischemic Cell Death Without Direct Tissue Contact. Stem Cells Dev (2016) 0.75
Serial in vivo imaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis. Exp Neurol (2016) 0.75
Distributed Features of Vimentin-Containing Neural Precursor Cells in Olfactory Bulb of SOD1G93A Transgenic Mice: a Study about Resource of Endogenous Neural Stem Cells. Int J Biol Sci (2016) 0.75
Functional and morphological assessment of diaphragm innervation by phrenic motor neurons. J Vis Exp (2015) 0.75
Immunohistochemical toolkit for tracking and quantifying xenotransplanted human stem cells. Regen Med (2014) 0.75
Stem cell therapy for amyotrophic lateral sclerosis. Cell Regen (Lond) (2015) 0.75
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature (1993) 21.65
Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science (1994) 18.08
Immunogenicity of induced pluripotent stem cells. Nature (2011) 7.31
Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci (2004) 6.99
Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science (2003) 6.35
ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron (1997) 6.16
An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron (1995) 6.03
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci (2008) 5.89
Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol (2009) 5.65
Astrocyte activation and reactive gliosis. Glia (2005) 5.46
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci U S A (2002) 4.37
Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med (1992) 3.71
Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol (1995) 3.66
Mechanisms of Disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol (2006) 3.42
Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain (1995) 2.99
Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci (2008) 2.67
Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J Neurosci (2001) 2.51
GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS One (2007) 1.99
Differential properties of adult rat and mouse brain-derived neural stem/progenitor cells. Mol Cell Neurosci (2006) 1.99
Lineage-restricted neural precursors survive, migrate, and differentiate following transplantation into the injured adult spinal cord. Exp Neurol (2005) 1.73
Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. Stem Cells (2006) 1.45
Disease progression of human SOD1 (G93A) transgenic ALS model rats. J Neurosci Res (2006) 1.24
Grafted lineage-restricted precursors differentiate exclusively into neurons in the adult spinal cord. Exp Neurol (2002) 1.23
Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS. Brain Res (2007) 1.20
Long-term fate of neural precursor cells following transplantation into developing and adult CNS. Neuroscience (2006) 1.20
Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS. Neurobiol Dis (2005) 1.16
Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats. Neurosci Lett (2011) 1.10
Selective ablation of proliferating astrocytes does not affect disease outcome in either acute or chronic models of motor neuron degeneration. Exp Neurol (2008) 1.02
Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice. Exp Mol Med (2009) 0.99
Differential generation of oligodendrocytes from human and rodent embryonic spinal cord neural precursors. Glia (2004) 0.97
Glutamate transporter expression and function in human glial progenitors. Glia (2004) 0.97
Expression profiling of human glial precursors. BMC Dev Biol (2008) 0.94
Peripheral hyperstimulation alters site of disease onset and course in SOD1 rats. Neurobiol Dis (2010) 0.92
Isolation, characterization and preclinical development of human glial-restricted progenitor cells for treatment of neurological disorders. Regen Med (2010) 0.92
Advances in stem cell research for Amyotrophic Lateral Sclerosis. Curr Opin Biotechnol (2009) 0.85
Targeted stem cell transplantation strategies in ALS. Neurochem Int (2006) 0.83
Sleep drives metabolite clearance from the adult brain. Science (2013) 9.65
Regulatory networks define phenotypic classes of human stem cell lines. Nature (2008) 4.98
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci U S A (2002) 4.37
Gene expression in human embryonic stem cell lines: unique molecular signature. Blood (2003) 3.73
Differences between human and mouse embryonic stem cells. Dev Biol (2004) 3.30
Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Blood (2007) 3.05
Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells (2005) 2.74
Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci (2008) 2.67
Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation. Nat Biotechnol (2004) 2.60
Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med (2005) 2.46
Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease. J Neurochem (2002) 2.45
Dopaminergic differentiation of human embryonic stem cells. Stem Cells (2004) 2.30
Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translation. Stem Cells Dev (2014) 2.27
Long-term culture of human embryonic stem cells in feeder-free conditions. Dev Dyn (2004) 2.01
Properties of a fetal multipotent neural stem cell (NEP cell). Dev Biol (2002) 1.75
Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. Stem Cells Dev (2004) 1.75
Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells (2010) 1.74
Membrane properties of rat embryonic multipotent neural stem cells. J Neurochem (2004) 1.73
CD44 expression identifies astrocyte-restricted precursor cells. Dev Biol (2004) 1.66
Qualification of embryonal carcinoma 2102Ep as a reference for human embryonic stem cell research. Stem Cells (2007) 1.62
Electrical impedance myography as a biomarker to assess ALS progression. Amyotroph Lateral Scler (2012) 1.62
Comparison of the gene expression profile of undifferentiated human embryonic stem cell lines and differentiating embryoid bodies. BMC Dev Biol (2005) 1.61
Properties of four human embryonic stem cell lines maintained in a feeder-free culture system. Dev Dyn (2004) 1.60
A targeted neuroglial reporter line generated by homologous recombination in human embryonic stem cells. Stem Cells (2009) 1.59
Assessing self-renewal and differentiation in human embryonic stem cell lines. Stem Cells (2005) 1.58
Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines. BMC Dev Biol (2006) 1.58
beta1 integrin maintains integrity of the embryonic neocortical stem cell niche. PLoS Biol (2009) 1.57
Nitric oxide acts in a positive feedback loop with BDNF to regulate neural progenitor cell proliferation and differentiation in the mammalian brain. Dev Biol (2003) 1.53
Exploiting the potential of large databases of electronic health records for research using rapid search algorithms and an intuitive query interface. J Am Med Inform Assoc (2013) 1.52
Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. J Comp Neurol (2007) 1.51
Cell-extracellular matrix interactions regulate neural differentiation of human embryonic stem cells. BMC Dev Biol (2008) 1.49
Developing safe therapies from human pluripotent stem cells. Nat Biotechnol (2009) 1.48
Evolution of the Pediatric Advanced Life Support course: enhanced learning with a new debriefing tool and Web-based module for Pediatric Advanced Life Support instructors. Pediatr Crit Care Med (2012) 1.47
Toward cell replacement therapy: promises and caveats. Exp Neurol (2003) 1.47
Myeloperoxidase-generated oxidants modulate left ventricular remodeling but not infarct size after myocardial infarction. Circulation (2005) 1.42
Sox2 expression defines a heterogeneous population of neurosphere-forming cells in the adult murine brain. Aging Cell (2005) 1.42
Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes. Exp Neurol (2005) 1.41
Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis. N Z Med J (2004) 1.40
Viral-induced spinal motor neuron death is non-cell-autonomous and involves glutamate excitotoxicity. J Neurosci (2004) 1.40
Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo. Proc Natl Acad Sci U S A (2011) 1.38
Amyotrophic lateral sclerosis: pathogenesis, differential diagnoses, and potential interventions. J Spinal Cord Med (2002) 1.38
Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them. PLoS One (2009) 1.38
Brg1 is required for murine neural stem cell maintenance and gliogenesis. Dev Biol (2005) 1.38
Assessment and management of patients who make threats against the president in the psychiatric emergency service. Psychiatr Serv (2005) 1.37
Properties of pluripotent human embryonic stem cells BG01 and BG02. Stem Cells (2004) 1.36
Creation of engineered human embryonic stem cell lines using phiC31 integrase. Stem Cells (2007) 1.35
Evidence that nucleocytoplasmic Olig2 translocation mediates brain-injury-induced differentiation of glial precursors to astrocytes. J Neurosci Res (2007) 1.31
Human embryonic germ cell derivatives facilitate motor recovery of rats with diffuse motor neuron injury. J Neurosci (2003) 1.31
Exome sequencing to identify de novo mutations in sporadic ALS trios. Nat Neurosci (2013) 1.31
Oligodendrocyte and astrocyte development in rodents: an in situ and immunohistological analysis during embryonic development. Glia (2002) 1.31
Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia (2006) 1.28
Adult glial precursor proliferation in mutant SOD1G93A mice. Glia (2008) 1.27
A novel serum-free medium for the expansion of human mesenchymal stem cells. Stem Cell Res Ther (2010) 1.26
Factors affecting availability of essential medicines among community health workers in Ethiopia, Malawi, and Rwanda: solving the last mile puzzle. Am J Trop Med Hyg (2012) 1.25
Evolutionarily conserved transcriptional co-expression guiding embryonic stem cell differentiation. PLoS One (2008) 1.24
Selective up-regulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection. Neurobiol Dis (2005) 1.23
Grafted lineage-restricted precursors differentiate exclusively into neurons in the adult spinal cord. Exp Neurol (2002) 1.23
Immortalized neural stem cells differ from nonimmortalized cortical neurospheres and cerebellar granule cell progenitors. Exp Neurol (2004) 1.23
BG01V: a variant human embryonic stem cell line which exhibits rapid growth after passaging and reliable dopaminergic differentiation. Restor Neurol Neurosci (2004) 1.22
A review of the methods for human iPSC derivation. Methods Mol Biol (2013) 1.22
Arthroscopic debridement of the isolated Ligamentum Teres rupture. Knee Surg Sports Traumatol Arthrosc (2010) 1.21
In search of "stemness". Exp Hematol (2004) 1.21
The stem-cell menagerie. Trends Neurosci (2003) 1.20
Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS. Brain Res (2007) 1.20
An efficient method for the derivation of mouse embryonic stem cells. Stem Cells (2005) 1.20
Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors. Mol Cell Neurosci (2004) 1.20
Establishing standards for the characterization of human embryonic stem cell lines. Stem Cells (2005) 1.17
Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS. Neurobiol Dis (2005) 1.16
MRI findings of femoroacetabular impingement. AJR Am J Roentgenol (2006) 1.15
Monitoring early differentiation events in human embryonic stem cells by massively parallel signature sequencing and expressed sequence tag scan. Stem Cells Dev (2004) 1.15
The microenvironment of the embryonic neural stem cell: lessons from adult niches? Dev Dyn (2007) 1.14
Echocardiographic predictors of successful versus unsuccessful mitral valve repair in ischemic mitral regurgitation. Am J Cardiol (2006) 1.13
Monitoring differentiation of human embryonic stem cells using real-time PCR. Stem Cells (2005) 1.11
Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysis. Sci Transl Med (2012) 1.10
Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infections. J Med Chem (2012) 1.09
SDF1alpha/CXCR4 signaling stimulates beta-catenin transcriptional activity in rat neural progenitors. Neurosci Lett (2006) 1.09
Which is the most useful patient-reported outcome in femoroacetabular impingement? Test-retest reliability of six questionnaires. Br J Sports Med (2013) 1.09
NTera2: a model system to study dopaminergic differentiation of human embryonic stem cells. Stem Cells Dev (2005) 1.08
Transplantation of human glial restricted progenitors and derived astrocytes into a contusion model of spinal cord injury. J Neurotrauma (2011) 1.08
Hip joint pathology: clinical presentation and correlation between magnetic resonance arthrography, ultrasound, and arthroscopic findings in 25 consecutive cases. Clin J Sport Med (2003) 1.07
Hes1 but not Hes5 regulates an astrocyte versus oligodendrocyte fate choice in glial restricted precursors. Dev Dyn (2003) 1.07
Global Characterization and Genomic Stability of Human MultiStem, A Multipotent Adult Progenitor Cell. J Stem Cells (2009) 1.06
Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing. ALTEX (2010) 1.06
A novel secretory factor, Neurogenesin-1, provides neurogenic environmental cues for neural stem cells in the adult hippocampus. J Neurosci (2003) 1.06
Building an evidence base on mental health interventions for children affected by armed conflict. Intervention (Amstelveen) (2008) 1.06
Neural precursor cells can be delivered into the injured cervical spinal cord by intrathecal injection at the lumbar cord. Brain Res (2005) 1.06
Embryonic stem cell research and U.S. policy. Stem Cells (2006) 1.06
Efficient generation of astrocytes from human pluripotent stem cells in defined conditions. Stem Cells (2013) 1.05
Glial progenitors in the CNS and possible lineage relationships among them. Biol Cell (2004) 1.05
Whole genome analysis of human neural stem cells derived from embryonic stem cells and stem and progenitor cells isolated from fetal tissue. Stem Cells (2007) 1.05
Human neural crest stem cells derived from human ESCs and induced pluripotent stem cells: induction, maintenance, and differentiation into functional schwann cells. Stem Cells Transl Med (2012) 1.05
Cellular lifespan and senescence signaling in embryonic stem cells. Aging Cell (2004) 1.04
Cytoplasmic translocation of Olig2 in adult glial progenitors marks the generation of reactive astrocytes following autoimmune inflammation. Exp Neurol (2006) 1.04
Electrical impedance myography correlates with standard measures of ALS severity. Muscle Nerve (2013) 1.03